English | Español
Jamie Barrand | Mar 15, 2016

Florida supplement company must cease with therapeutic claims

Jamie Barrand | Mar 15, 2016

FDA grants orphan drug designation to neuromyelitis optica therapy
Jamie Barrand | Mar 13, 2016

AHA releases statement detailing differences between heart disease in men, women
Jamie Barrand | Mar 13, 2016

FDA approves breast cancer therapy for additional indications
Jamie Barrand | Mar 13, 2016

ASHP officials request clarification on Drug Quality and Security Act mandates
Amanda Rupp | Mar 13, 2016

Lupus Foundation launches initiative to improve clinical trials
Amanda Rupp | Mar 11, 2016

Merck launches study on treatment of inflammatory illnesses
Jeff Gantt | Mar 11, 2016

Vical to move forward with antifungal treatment trial

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’